NO991729D0 - Anti-p53-enkeltkjede-antistoff-fragmenter og deres anvendelse - Google Patents

Anti-p53-enkeltkjede-antistoff-fragmenter og deres anvendelse

Info

Publication number
NO991729D0
NO991729D0 NO991729A NO991729A NO991729D0 NO 991729 D0 NO991729 D0 NO 991729D0 NO 991729 A NO991729 A NO 991729A NO 991729 A NO991729 A NO 991729A NO 991729 D0 NO991729 D0 NO 991729D0
Authority
NO
Norway
Prior art keywords
antibody fragments
single chain
chain antibody
concerns
restoring
Prior art date
Application number
NO991729A
Other languages
English (en)
Other versions
NO326452B1 (no
NO991729L (no
Inventor
Laurent Bracco
Laurent Debussche
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO991729D0 publication Critical patent/NO991729D0/no
Publication of NO991729L publication Critical patent/NO991729L/no
Publication of NO326452B1 publication Critical patent/NO326452B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19991729A 1996-10-29 1999-04-13 Anvendelse av et enkeltkjede-antistoff eller en nukleinsyre som koder for dette for fremstilling av en farmasoytisk sammensetning for behandling av cancer hvor et mutert p53 protein er involvert, samt 11D3 molekylet og nukleinsyren som koder for dette og sammensetninger omfattende disse. NO326452B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613176A FR2755144B1 (fr) 1996-10-29 1996-10-29 Fragments d'anticorps a chaine unique anti-p53 et utilisation
PCT/FR1997/001921 WO1998018825A1 (fr) 1996-10-29 1997-10-27 Fragments d'anticorps a chaine unique anti-p53 et utilisations

Publications (3)

Publication Number Publication Date
NO991729D0 true NO991729D0 (no) 1999-04-13
NO991729L NO991729L (no) 1999-04-13
NO326452B1 NO326452B1 (no) 2008-12-08

Family

ID=9497134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991729A NO326452B1 (no) 1996-10-29 1999-04-13 Anvendelse av et enkeltkjede-antistoff eller en nukleinsyre som koder for dette for fremstilling av en farmasoytisk sammensetning for behandling av cancer hvor et mutert p53 protein er involvert, samt 11D3 molekylet og nukleinsyren som koder for dette og sammensetninger omfattende disse.

Country Status (21)

Country Link
US (1) US6852509B1 (no)
EP (1) EP0941252B1 (no)
JP (1) JP4371178B2 (no)
KR (1) KR100874789B1 (no)
AT (1) ATE380198T1 (no)
AU (1) AU745530B2 (no)
BR (1) BR9712575A (no)
CA (1) CA2268865C (no)
CZ (1) CZ300526B6 (no)
DE (1) DE69738352T2 (no)
DK (1) DK0941252T3 (no)
ES (1) ES2297853T3 (no)
FR (1) FR2755144B1 (no)
HU (1) HU226330B1 (no)
IL (2) IL129476A0 (no)
NO (1) NO326452B1 (no)
PT (1) PT941252E (no)
SI (1) SI0941252T1 (no)
SK (1) SK286978B6 (no)
WO (1) WO1998018825A1 (no)
ZA (1) ZA979738B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121041A0 (en) 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
US7199809B1 (en) 1998-10-19 2007-04-03 Symyx Technologies, Inc. Graphic design of combinatorial material libraries
AUPP932199A0 (en) * 1999-03-19 1999-04-15 St Vincent's Hospital Sydney Limited Anti-p53 antibodies
AU769679B2 (en) * 1999-03-19 2004-01-29 St Vincent's Hospital Sydney Limited Anti-p53 antibodies
DE19962583A1 (de) * 1999-12-23 2001-06-28 Mueller Hermelink Hans Konrad Antikörper gegen Plasmazellen
US6630584B1 (en) * 2000-03-16 2003-10-07 Ramot At Tel-Aviv University Ltd. Single chain antibody against mutant p53
CN1909927A (zh) * 2003-12-24 2007-02-07 株式会社洛科摩基因 抑制癌的方法
JPWO2005061007A1 (ja) * 2003-12-24 2007-07-12 学校法人 聖マリアンナ医科大学 癌の抑制方法
GB0420771D0 (en) * 2004-09-17 2004-10-20 Randox Lab Ltd Antibody
WO2006100681A2 (en) * 2005-03-25 2006-09-28 Ramot At Tel Aviv University Ltd. Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
WO2007028117A2 (en) * 2005-09-02 2007-03-08 New England Medical Center Hospitals, Inc. P8 as a marker for heart failure
MY198194A (en) * 2016-05-02 2023-08-09 Prothena Biosciences Ltd Antibodies Recognizing Tau

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
FR2736915B1 (fr) 1995-07-19 1997-08-22 Rhone Poulenc Rorer Sa Variants de la proteine p53 et utilisations therapeutiques

Also Published As

Publication number Publication date
SK55899A3 (en) 2000-06-12
SI0941252T1 (sl) 2008-04-30
FR2755144A1 (fr) 1998-04-30
WO1998018825A1 (fr) 1998-05-07
CA2268865C (fr) 2011-01-04
US6852509B1 (en) 2005-02-08
DE69738352T2 (de) 2008-11-13
KR100874789B1 (ko) 2008-12-18
IL129476A (en) 2010-05-17
NO326452B1 (no) 2008-12-08
ATE380198T1 (de) 2007-12-15
CZ300526B6 (cs) 2009-06-10
JP2001502553A (ja) 2001-02-27
AU745530B2 (en) 2002-03-21
BR9712575A (pt) 1999-10-19
ZA979738B (en) 1998-05-22
HUP9904199A1 (hu) 2000-04-28
EP0941252B1 (fr) 2007-12-05
ES2297853T3 (es) 2008-05-01
FR2755144B1 (fr) 1998-11-27
DK0941252T3 (da) 2008-03-31
HUP9904199A3 (en) 2000-09-28
JP4371178B2 (ja) 2009-11-25
DE69738352D1 (de) 2008-01-17
SK286978B6 (sk) 2009-08-06
NO991729L (no) 1999-04-13
CZ145599A3 (cs) 1999-08-11
IL129476A0 (en) 2000-02-29
HU226330B1 (en) 2008-09-29
KR20000052845A (ko) 2000-08-25
EP0941252A1 (fr) 1999-09-15
AU4952097A (en) 1998-05-22
PT941252E (pt) 2008-03-07
CA2268865A1 (fr) 1998-05-07

Similar Documents

Publication Publication Date Title
GB2338237A (en) In vitro peptide or protein expression library
CA2282497A1 (en) In vitro peptide or protein expression library
DE60335000D1 (de) In vitro peptid-expressionsbank
ATE544776T1 (de) Chimäre dna-bindeproteine
IL131016A0 (en) Selection of proteins using rna-protein fusions
EP0804609A4 (en) NEW GENES OF RESPONSE p53
DE69839444D1 (de) Smad 6 und dessen anwendungen
NO991729D0 (no) Anti-p53-enkeltkjede-antistoff-fragmenter og deres anvendelse
DE69533359D1 (de) Veränderte menschliche c3-proteine
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE427959T1 (de) Gereinigtes sr-p70 protein
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
WO2001066752A3 (en) Reproduction-specific genes
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2002012541A3 (en) Novel motor proteins and methods for their use
NZ512332A (en) Potassium channel interactors and uses therefor
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
WO2004029276A3 (en) Nucleic acids encoding a mammalian raptor polypeptide and uses therefor
WO2002079479A3 (en) Motor proteins and methods for their use
WO2001098314A3 (en) Novel motor proteins and methods for their use
WO2001021794A3 (en) Smad associating polypeptides
TH30275A (th) โปรตีนดัดแปลง
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
WO1999047668A3 (de) Für tumorsuppressorproteine kodierende nukleinsäure, tumorsuppressorproteine, verfahren zu deren herstellung, antikörper gegen tumorsuppressorproteine und verwendung dieser gegenstände

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees